First Trust Bloomberg R&D Leaders ETF (NYSEARCA:RND) Sees Significant Growth in Short Interest

Posted by Doug Wharley on Nov 1st, 2026

First Trust Bloomberg R&D Leaders ETF (NYSEARCA:RND – Get Free Report) was the target of a large growth in short interest in October. As of October 15th, there was short interest totaling 940 shares. Based on an average daily trading volume, of 2,404 shares, the short-interest ratio is presently 0.4 days. Approximately 0.3% of the shares of the stock are sold short.

First Trust Bloomberg R&D Leaders ETF Price Performance

RND traded down $0.69 during midday trading on Friday, reaching $32.42. 304 shares of the company’s stock were exchanged, compared to its average volume of 2,512. The stock has a market capitalization of $9.73 million, a PE ratio of 34.30 and a beta of 1.23. The business’s 50-day moving average price is $33.25 and its 200 day moving average price is $31.21. First Trust Bloomberg R&D Leaders ETF has a 1-year low of $26.25 and a 1-year high of $34.41.

Institutional Investors Weigh In On First Trust Bloomberg R&D Leaders ETF

A number of institutional investors and hedge funds have recently bought and sold shares of RND. IFP Advisors Inc raised its holdings in shares of First Trust Bloomberg R&D Leaders ETF by 12.9% in the third quarter. IFP Advisors Inc now owns 7,292 shares of the company’s stock worth $245,000 after acquiring an additional 831 shares during the last quarter. GK Wealth Management LLC purchased a new stake in shares of First Trust Bloomberg R&D Leaders ETF in the third quarter valued at $25,000. Finally, Citadel Advisors LLC acquired a new stake in shares of First Trust Bloomberg R&D Leaders ETF during the second quarter valued at $1,037,000.

First Trust Bloomberg R&D Leaders ETF Company Profile

(Get Free Report)

The First Trust Bloomberg R&D Leaders ETF (RND) is an exchange-traded fund that is based on the Bloomberg R&D Leaders Select TR index. The fund tracks a market cap-weighted index of 30-50 US stocks with substantial expenditures dedicated to research and development. RND was launched on Apr 30, 2024 and is issued by First Trust.